HIV Treatment Guidelines for Children

Introduction to HIV Treatment

The Centers for Disease Control and Prevention recommends that all HIV-infected children should receive combination antiretroviral therapy (cART) with at least three drugs—specifically two NRTIs plus one protease inhibitor—to maximally suppress viral replication and preserve immune function 1, 2, 3, 4

Infants under 12 months should start treatment immediately upon confirmed HIV diagnosis, regardless of symptoms, CD4 count, or viral load 5, 6, 7
The American Academy of Pediatrics recommends that infants are at highest risk for rapid disease progression 6, 7
Critical consideration: Assess caregiver adherence capacity before initiating therapy, as subtherapeutic drug levels (especially protease inhibitors) rapidly lead to resistance development 6, 7

The Centers for Disease Control and Prevention recommends a standard regimen of two NRTIs plus one protease inhibitor 1, 2, 3, 4
This combination slows disease progression, improves survival, achieves greater viral suppression, and delays resistance development 1, 2, 3, 4
Goal: Reduce HIV RNA to undetectable levels 1, 2, 3, 4

Change in immune classification category 8
For CD4 <15%: Persistent decline of ≥5 percentiles (e.g., 15%→10% or 10%→5%) 8
Rapid substantial decrease in absolute CD4 count (>30% decline in <6 months) 8
Confirm with repeat measurement at least 1 week after initial test 8
The World Health Organization recommends changing the regimen for clinical failure, such as progressive neurodevelopmental deterioration, growth failure, or disease progression to more advanced clinical category 8